Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HLIO | Common Stock | Options Exercise | $18.2K | +404 | +2.72% | $44.98 | 15.2K | Feb 26, 2025 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HLIO | Performance-Based Restricted Stock Units | Options Exercise | $0 | -404 | -100% | $0.00 | 0 | Feb 26, 2025 | Common Stock | 404 | $0.00 | Direct | F1 |
Id | Content |
---|---|
F1 | Acquired performance-based restricted stock units granted to reporting person on January 3, 2022, which represent the right to receive, following vesting, up to 200% of one share of the Company's Common Stock. The number of shares of Common Stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee over a three-year performance period beginning on the first day of the fiscal year of 2022 and ending on the last day of the fiscal year of 2024. The payout percentage for the grant based on performance goals was 31%. |